Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ping An AskBob Doctor's Smart Imaging Model for Diagnosis of Pelvic and Hip Injuries is a Breakthrough for Artificial Intelligence 2021-04-01 17:17
Jolly Good Newly Establishes CBT VR Specialist Department with Clinical Psychiatrists 2021-04-01 16:00
Yingli Pharma announce promising topline results of a Phase II registration study for treatment of relapsed/refractory follicular lymphoma with the once daily oral PI3Kδ inhibitor, linperlisib 2021-04-01 14:09
Frontier Pharma and Baystone Group completes its acquisition of Zdravlje, a high quality pharmaceutical manufacturer in Serbia 2021-04-01 13:00
First-pass success in mechanical thrombectomy lowers costs in treatment of acute ischemic stroke in Asia Pacific 2021-04-01 11:15
Alfasigma: It's Vein Week from 5th to 11th of April 2021-04-01 08:35
Ortho Announces Plans to Accelerate COVID-19 Antigen and Antibody Test Development Through New Contract with BARDA and the Department of Defense 2021-04-01 08:03
Increased Virtual Learning Impacts Children's Vision 2021-04-01 04:45
Iconovo signs agreement with ISR for the development of inhaled covid-19 vaccine 2021-04-01 03:19
Ascentage Pharma Announces 2020 Annual Results and Reports Launch Readiness for Its Core Drug Candidate 2021-03-31 23:27
Five New 'Key Opinion Leaders' Appointed to Blinkcns Scientific Advisory Board 2021-03-31 21:00
Gracell Biotechnologies Signs Agreement with Lonza to Manufacture Gracell's FasTCAR Product Candidates in the U.S. 2021-03-31 20:45
Gracell Biotechnologies Announces Enrollment of First Patient in Registrational Phase 1/2 Clinical Study for GC007g, an Allogeneic CAR-T Cell Therapy for the Treatment of Relapsed or Refractory B-ALL 2021-03-31 20:00
BIOVAXYS files FDA pre-IND meeting request and briefing package for COVID-T 2021-03-31 20:00
AffaMed Therapeutics and SIFI Announce Joint Venture to Serve Greater China Market 2021-03-31 19:30
Future Health: Innovative Health Around the World 2021-03-31 18:36
CStone Announces China NMPA New Drug Approval of Precision Therapy AYVAKIT® (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor 2021-03-31 18:20
Evive Biotech Submits Biologics License Application to US FDA for Ryzneuta(TM) 2021-03-31 11:26
Cigna Study Shows Uncertainty about the Future as Leading Cause of Stress 2021-03-31 11:09
Everest Medicines Announces China NMPA Approval of Clinical Trial Application to Evaluate Trodelvy® in a Phase 2 Basket Trial for a Variety of Cancers with High TROP-2 Expression 2021-03-31 10:27
1 408 409 410 411 412 896